- Report
- July 2019
- 41 Pages
- Report
- July 2019
- 23 Pages
- Report
- January 2019
- 123 Pages
- Report
- March 2020
- 35 Pages
- Report
- July 2019
- 19 Pages
- Report
- March 2021
- 44 Pages
From €1966EUR$1,950USD£1,687GBP
- Report
- January 2021
- 43 Pages
From €499EUR$495USD£428GBP
- Report
- July 2020
- 164 Pages
From €4992EUR$4,950USD£4,283GBP
- Report
- July 2020
- 28 Pages
From €7563EUR$7,500USD£6,489GBP
- Report
- May 2020
- 7 Pages
From €908EUR$900USD£779GBP
- Report
- May 2020
- 7 Pages
From €908EUR$900USD£779GBP
- Report
- May 2020
- 7 Pages
From €908EUR$900USD£779GBP
- Report
- May 2020
- 7 Pages
From €908EUR$900USD£779GBP
- Report
- May 2020
- 7 Pages
From €908EUR$900USD£779GBP
- Report
- May 2020
- 7 Pages
From €908EUR$900USD£779GBP
- Report
- July 2019
- 23 Pages
- Report
- January 2019
- 41 Pages
- Report
- January 2019
- 17 Pages
From €3993EUR$3,960USD£3,426GBP

The term Pharmaeconomics describes a scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is not just an effective way to analyse and measure the pharmaceutical industry, but also for industry players to gain a competitive advantage and new market entrants to accurately identify where the best commercial opportunities lie.
Whether by cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis or cost-utility analysis, the reports, books, and journals listed under in Research and Markets’ Pharmaeconomics category enable buyers to more accurately apply pharmaeconomics, and to study case histories of these principles put into effective real life action by pharmaceutical companies.
From academic books that introduce students to a set of analytical tools of economic evaluations and their applications in the health sector to special reports covering every aspect of the drug development pipeline (from production and pricing to reviewing portfolios), you will find in this section the information resource that you need. Show Less Read more